To validate the in-silico association of MCM10 expression and DDR activation, and to see the cellular protein levels of DDR proteins in the relevance of MCM10, we performed IHC staining in clinical BC patients specimens with grade 1, grade 2 and grade 3 of BC malignancy. This evidence concerns the gene DDR1 and breast cancer.